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A zebrafish model of Poikiloderma 
with Neutropenia recapitulates 
the human syndrome hallmarks 
and traces back neutropenia to the 
myeloid progenitor
Elisa A. Colombo1, Silvia Carra2, Laura Fontana1, Erica Bresciani2,3, Franco Cotelli2,* & 
Lidia Larizza1,4,*
Poikiloderma with Neutropenia (PN) is an autosomal recessive genodermatosis characterized 
by early-onset poikiloderma, pachyonychia, hyperkeratosis, bone anomalies and neutropenia, 
predisposing to myelodysplasia. The causative C16orf57/USB1 gene encodes a conserved 
phosphodiesterase that regulates the stability of spliceosomal U6-RNA. The involvement of USB1 in 
splicing has not yet allowed to unveil the pathogenesis of PN and how the gene defects impact on 
skin and bone tissues besides than on the haematological compartment. We established a zebrafish 
model of PN using a morpholino-knockdown approach with two different splicing morpholinos. Both 
usb1-depleted embryos displayed developmental abnormalities recapitulating the signs of the human 
syndrome. Besides the pigmentation and osteochondral defects, usb1-knockdown caused defects in 
circulation, manifested by a reduced number of circulating cells. The overall morphant phenotype 
was also obtained by co-injecting sub-phenotypic dosages of the two morpholinos and could be 
rescued by human USB1 RNA. Integrated in situ and real-time expression analyses of stage-specific 
markers highlighted defects of primitive haematopoiesis and traced back the dramatic reduction in 
neutrophil myeloperoxidase to the myeloid progenitors showing down-regulated pu.1 expression. 
Our vertebrate model of PN demonstrates the intrinsic requirement of usb1 in haematopoiesis and 
highlights PN as a disorder of myeloid progenitors associated with bone marrow dysfunction.
Poikiloderma with Neutropenia, Clericuzio-type (PN; OMIM#604173) is a rare autosomal reces-
sive genodermatosis affecting the skin and the haematopoietic system, in particular the myeloid lin-
eage. It is characterized by early onset poikiloderma, a cutaneous lesion with a pattern of reticulated 
hypo-hyper-pigmentation, mild atrophy and telangiectasias, pachyonychia, palmo-plantar hyperkerato-
sis, bone alterations and non-cyclic neutropenia, usually revealed by recurrent infections during infancy 
and childhood1–5. Discovery of the causative C16orf57 gene by autozygosity mapping and next-generation 
sequencing of the linkage region on chromosome 166, confirmed that PN is genetically distinct from clin-
ically overlapping entities, in particular Rothmund-Thomson syndrome (OMIM#268400), and allowed 
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the introduction of the genetic test to validate diagnosis and provide patients with the appropriate onco-
logical surveillance7–11. Neutropenia, the distinctive PN hallmark, confers on patients a high risk to 
develop myelodysplasia, often evolving into acute myeloid leukaemia in the second decade of life12,13.
The C16orf57 gene, renamed USB1 (U six biogenesis 1), is phylogenetically conserved and ubiqui-
tously expressed, suggesting a housekeeping function6,12.
Computational analysis of the encoded protein shows two conserved H-X-S/T-X tetra-peptide motifs 
(2H), which mark the active site of a 2-fold pseudosymmetric structure5. The signature of the 2H motifs, 
characteristic of the 2H phosphoesterase family14,15, suggested that the USB1 protein was likely to be 
involved in RNA processing, leading to the prediction that all the reported USB1 loss-of-function muta-
tions cause disruption of both protein folding and catalytic site5.
Recently, it has been demonstrated that in Saccharomyces cerevisiae and human cells the USB1 gene 
and its yeast ortholog encode a phosphodiesterase that is essential for the biogenesis of the RNA splicing 
apparatus as it regulates the stability of U6 small nuclear RNA (snRNA)16,17. X-ray crystallography of the 
human USB1 protein has definitely confirmed that USB1 is an RNase that trims the 3′ end of the U6 
transcript implicating aberrant oligoadenylation of U6 snRNA in the pathogenesis of PN18. While these 
insights advance our understanding of the PN pathomechanism, how USB1 mutations impact on the 
morphogenesis and differentiation of tissues affected in PN remains unknown.
To address this issue, we have exploited the zebrafish as a model organism. Zebrafish has a single 
USB1 ortholog, which is ubiquitously expressed during early development. Using a morpholino (MO) 
knockdown approach, we show that the morphants display developmental abnormalities that reproduce 
the signs of the human syndrome, namely defective pigmentation, osteochondral alterations and severe 
haematopoietic defects, mainly affecting the myeloid lineage.
Results
Identification and characterization of the zebrafish usb1 gene. We performed BLAST searches 
with the human USB1 gene and protein sequences to identify the zebrafish ortholog in the database 
(usb1, NM_001003460.1), which is present in only one copy in the zebrafish genome.
The genomic structure of USB1 and usb1 orthologs is similar, with 7 exons in both cases (Fig.  1a) 
and the USB1- and usb1-containing regions on human chromosome 16q21 and zebrafish chromosome 
25 are fairly syntenic.
The encoded human and zebrafish proteins are 265 and 276 amino acids (aa) in length, respectively, 
with a sequence similarity and identity of 73.4% and 46%, respectively. The difference in length between 
the genomic usb1 sequence (9452 bp) and that of USB1 (22072 bp) is accounted for by shorter usb1 
introns (Fig. 1a).
Alignment of the entire human and zebrafish protein sequences shows a highly evolutionarily con-
served amino acids sequence from the 51st to the last aa residue (Fig. 1b).
The zebrafish protein shares with the human protein the distinctive series of secondary structure ele-
ments (α -helices and β-strands) and has the two HLSL motifs (boxed in Fig. 1b,c), which are the main 
part of the catalytic site in the human protein5,16–18.
Expression profile of usb1 during zebrafish development. Analysis of usb1 expression during 
zebrafish embryonic development by reverse transcription-PCR (RT-PCR) showed that usb1 transcript 
was both maternally and zygotically expressed (Fig. 2a). In adult animals, usb1 expression was recorded 
in all analysed tissues (brain, eyes, liver, gills, heart, muscle, ovary and testis) (Fig. 2a).
Whole-mount in situ hybridization analysis (WISH) with an antisense probe targeting the full-length 
transcript (1,126 bp) was also used to characterize usb1 expression patterns during embryo development 
(Fig. 2b). At early developmental stages, from two cells up to the 5 somites stage, usb1 expression was 
ubiquitous and consistent with the expression found by RT-PCR (Fig. 2a). By the 15 somites stage until 
26 hours post fertilization (hpf), expression of usb1 was higher in the anterior head region than in the 
posterior tail (Fig. 2b). From 26 hpf, usb1 transcripts were detected in the cephalic region and in specific 
trunk regions that at 36 hpf were recognized as the pharyngeal arches, the budding liver and the pectoral 
fins, while no expression was observed in the caudal region (Fig. 2b). At 36 hpf the expression persisted 
only in the anterior head and trunk regions (Fig. 2b). No signal was observed in embryos at the same 
developmental stage when stained with usb1 sense probe (Fig. 2b).
Design and validation of splice-blocking morpholinos. To investigate the role of usb1 dur-
ing zebrafish embryogenesis, we performed loss-of-function experiments using MO-mediated gene 
knockdown.
We injected two different splice-blocking MOs, SMO-A and SMO-B, targeting the usb1 sequence 
between the IVS2 splice acceptor site and exon 3, and between the IVS4 splice acceptor site and exon 5, 
respectively (Fig. 3a).
Specific effects of SMO-A and SMO-B on usb1 mRNA splicing were confirmed by RT-PCR, which 
showed a severe reduction in the amount of normal splice products and the formation of aberrant tran-
scripts (Fig. 3b).
Sequence analysis revealed that the SMO-A misspliced amplicon of 363 bp was characterized by the 
out-of-frame skipping of exon 3. The corresponding aberrant transcript should result in a truncated 
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Figure 1. The human USB1 gene, the zebrafish usb1 ortholog and the encoded proteins. (a) Schematic 
genomic structure of USB1 and usb1. The lengths, not to scale, of exons (boxes), UTRs and introns 
(interconnecting bars) are indicated below and over the scheme, respectively. The encoded proteins 
share 73.4% and 46% sequence similarity and identity, respectively. (b) BLAST alignment of the human 
(NP_078874.2) and zebrafish (NP_001003460.1) usb1 proteins. Identical amino-acid residues and residues 
with the same polarity can be noted in several positions. Vertical dotted lines highlight the conserved 
intron–exon junctions with flanking numbers denoting exon number. The two histidine-serine residues of 
the HLSL motifs that are a main part of the catalytic site of the protein5,16 are boxed. (c) Prediction of the 
secondary usb1 protein structure using the PSIPRED server (http://bioinf.cs.ucl.ac.uk/psipred/). Barrels 
represent the α -helices and arrows the β-strands. The two histidine-serine residues of the HLSL motifs are 
boxed.
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protein (107 aa instead of 276 aa) lacking both HLSL motifs and therefore likely to be non-functional as 
the HLSL motifs are essential for the enzymatic function of the protein (Fig. 3c). The SMO-B aberrant 
transcript skipped exon 5, resulting in a protein that was missing the second of the two functionally 
relevant HLSL motifs (Fig. 3c).
Figure 2. Expression profiling of usb1 in zebrafish. (a) Temporal and spatial usb1 expression during 
embryogenesis and among adult tissues. Total RNA was extracted from embryos at the indicated time-points 
and from the specified adult tissues, and subjected to RT-PCR with primers specific for usb1 (upper panel) 
or β-actin (lower panel). The sizes of the obtained PCR fragments are indicated. (b) WISH analysis of usb1. 
The signal obtained with usb1 antisense probe was ubiquitous until the 5-somite stage. It showed a higher 
intensity in the cephalic region at the 15 somites stage and displayed decreasing expression from the head 
to the caudal region (20 somites and 26 hpf). At 36 hpf, the signal only marked the head and the pharyngeal 
arches-derived structures. hpf: hour post fertilization; dpf: day post fertilization. Images showing the results 
obtained with sense probe are provided at each developmental stage. Scale bars: 200 μ m.
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Overall phenotype of usb1-morphants. Following injection of SMO-A or SMO-B (each at a dosage 
of 0.6 pmol/embryo) into 1–2-cell embryos, specific defects could be observed in a consistent percentage 
of both morphant embryos at two (Fig. 4a) and five days post-fertilization (dpf; Fig. 4b) as compared to 
control embryos injected with the control MO (Std-MO) (Table 1).
At 2 dpf, most of SMO-A morphants appeared smaller than the controls, with smaller head, and 80% 
had pericardial oedema. Interestingly, 58% of the SMO-A-injected embryos (grown without 1-phenyl-
2-thiourea) displayed a defective and scattered pattern of spotted pigment in the skin and eyes as com-
pared to the Std-MO embryos (Fig. 4a and Table 1). At 2 dpf the phenotype of SMO-B morphants was 
remarkably similar to that of SMO-A morphants as they showed reduced body size, pericardial oedema 
(59%) and pigmentation defects (12%) (Fig. 4a and Table 1).
Furthermore, in vivo analysis at 2 dpf showed that about half of both SMO-A and SMO-B morphants 
had severe blood circulation defects ranging from a complete absence to reduced numbers of circulating 
cells (Table 1), despite a beating heart. WISH analysis of the cardiac myosin light chain 2 (cmlc2) expres-
sion did not show differences in the 2 dpf SMO-A and SMO-B morphants as compared to the controls, 
thus excluding heart morphology defects (Supplementary Fig. S1).
At 5 dpf, the majority of usb1-morphants never gained circulation and developed severe oedema 
extending to both the trunk and the yolk (Fig. 4b).
As the cardiac oedema and pigmentation defects observed in the usb1-morphants can be ascribed 
to an abnormal patterning of derivatives of the neural crest cells19, we explored the extent of usb1 
Figure 3. Efficiency of usb1 knockdown by splice-blocking morpholino SMO-A, targeting IVS2 acceptor 
splice site, and SMO-B, blocking IVS4 acceptor splice site. (a) Schematic diagram of zebrafish usb1 gene 
organization and position of SMO-A (blue) and SMO-B (red). Blue and red arrows indicate the positions 
of primer pairs used to detect the presence of aberrantly spliced usb1 transcripts obtained with SMO-A 
(primers F2-R3, Supplementary Table S1) and SMO-B (primers F-R2, Supplementary Table S1), respectively. 
(b) RT-PCR analysis of usb1 transcripts from embryos injected with SMO-A, SMO-B or Std-MO (each at 
0.6 pmol/embryo). SMO-A morphants exhibited aberrantly spliced products (363 bp) as compared to Std-
MO-injected embryos (547 bp) due to skipping of exon 3 (184 bp), frameshift, and exposure of a stop codon 
24 nucleotides downstream. SMO-B morphants exhibited aberrantly spliced products (1020 bp) as compared 
to Std-MO-injected embryos (1126 bp) due to skipping of exon 5 (106 bp) following the block of the IVS4 
acceptor splice site. MW, molecular weight markers. (c) Schematic representation of SMO-A- and SMO-B-
mediated misspliced transcripts inferred by sequencing. Aberrant proteins are predicted in both cases as the 
107 aa SMO-A-translated protein should lack both HLSL motifs, while the 184 aa SMO-B-translated protein 
should lack the second HLSL motif.
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Figure 4. Overall phenotype of usb1 morphants. Representative live-microscopy-4X magnification-
pictures of 2 dpf (a) and 5 dpf (b) embryos injected with the same dosage (0.6 pmol/embryo) of Std (top), 
SMO-A (central) or SMO-B (bottom) morpholinos. The morphants display a smaller size, with defective 
and irregular pigmentation of the skin, as compared to the continuous stripes of the control embryos, 
and pericardial oedema. (c) Massive skeletal defects revealed by Alcian blue staining in usb1 morphants 
at 5 dpf. From left to right: diagram illustrating the normal pharyngeal arches-derived bone architecture19; 
ventral view of a control embryo (left panel) and representative pictures of the mild (left) and severe (right) 
phenotypes of SMO-A and SMO-B morphants. The Meckel’s (yellow in the colour-coded diagram), the 
palatoquadrate (green) and ceratohyal (purple) structures appear misshaped in both mildly- and severely-
affected embryos; moreover, the ceratobranchial structures (light blue) appear disorganized or missing in 
half of SMO-A and in a third of SMO-B severely-affected embryos. (d) Reduction of gata1-positive cells 
(red fluorescence) (middle panels) and a regular vasculature pattern (green fluorescence) (lower panels) in 
2 dpf tg(gata1:dsRED;flk1:GFP) embryos injected with SMO-A (0.7 pmol/embryo) (right) as compared to 
control (left). (e) Myeloid lineage defects evinced by a reduction in mpx-positive cells (green fluorescence) 
(lower panels) in 2 dpf tg(mpx:GFP;lyzC:dsRED) embryos injected with SMO-A (0.7 pmol/embryo) (right) as 
compared to control (left). Scale bars: (a–e) 200 μ m.
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loss-of-function on another neural crest-specified process, chondrogenesis, by staining the cartilage of 
the skull and pharyngeal skeleton of 5 dpf embryos with Alcian Blue.
As shown in Fig. 4c and detailed in Table 1, 89% of Std-MO-injected larvae displayed a normal car-
tilages architecture. By contrast, 5 dpf embryos injected with either SMO-A or SMO-B (Fig. 4c, central 
and right panels) displayed either mild or severe craniofacial defects (Table 1). We consider the “mild” 
phenotype to be mainly characterized by abnormalities of the first two pharyngeal arches P1 (misshaped 
Meckel’s cartilage/lower jaw and misjoined to the palatoquadrate) and P2 (kinked and displaced cer-
atohyal cartilage), with grossly preserved posterior pharyngeal arches P3-P7. The “severe” phenotype 
was defined as reduced or absent P3-P7 bilateral branchial arches associated with the P1 and P2 defects 
mentioned above.
Among the SMO-A morphants, cartilage alterations were observed in 81% of the examined embryos 
with 31% in the mild and 50% in the severe phenotype subgroups (Table 1). Of the SMO-B morphants, 
59% displayed the cartilage alterations, 27% with the mild and 32% with the severe phenotype (Table 1).
Haematopoietic defects of usb1-morphants. To investigate the lineage-specific effect of 
usb1-knockdown on embryonic haematovascular morphogenesis and for further analysis of the circu-
lation defects observed in usb1-morphants, we used the tg(gata1:dsRED;flk1:GFP) zebrafish line, which 
is transgenic for the red cell progenitor marker gata1 and the vascular marker flk1. At 2 dpf, 62% of 
tg(gata1:dsRED;flk1:GFP) SMO-A morphants showed a reduction in gata1-positive cells in the context 
of a grossly regular vasculature pattern (Fig. 4d, Table 1).
Another transgenic line, tg(mpx:GFP;lyzC:dsRED), in which the promoter of the myeloid-specific 
marker myeloperoxidase (mpx) drives the expression of GFP protein, was used to investigate neutro-
phils. At 2 dpf, a reduction in mpx-expressing cells was observed in 70% of tg(mpx:GFP;lyzC:dsRED) 
SMO-A-injected embryos (Fig. 4e, Table 1).
These data prompted us to focus on the effects of usb1-knockdown on the primitive haematopoi-
etic cascade in the SMO-A morphants using WISH and real-time PCR analysis. The real-time PCR 
analysis evidenced a substantial decrease in expression (40%) of the myeloid progenitor marker pu.1 in 
10 somites SMO-A morphants, whereas expression of the erythroid progenitor marker gata1 was not 
perturbed (Fig. 5a). At 22 hpf, WISH and real-time PCR analysis showed only slightly decreased gata1 
levels (20%) (Fig.  5a,b), but at 30 hpf, gata1-expression levels in SMO-A and Std-MO embryos were 
similar (Fig. 5a).
In agreement with the data obtained with the tg(mpx:GFP;lyzC:dsRED) morphants, the 
terminally-differentiated neutrophil marker mpx was shown to be significantly reduced in the 
SMO-A-injected embryos: real-time PCR analysis showed 60% and 40% decreased expression levels 
of mpx in 22 hpf (p = 0.002) and 30 hpf morphants (p = 0.0096), respectively (Fig.  5a), fairly matching 
WISH results (Fig. 5b).
To determine whether red cell maturation was affected by usb1-knockdown, O-dianisidine staining 
for haemoglobin was performed. At 2 dpf, a reduction of the mature red blood cells was observed in 77% 
of SMO-A and 61% of SMO-B morphants, compared with a reduction in only 13% of Std-MO-injected 
embryos (Fig. 5c). Two subgroups could be identified: one with a slight and one with a severe reduction 
in haemoglobinized erythrocytes. The slightly reduced red cell phenotype was 43% for SMO-A and 27% 
for SMO-B morphants. A similar percentage of SMO-A (33%) and SMO-B (34%) embryos showed the 
severe phenotype.
Ruling out off-target effects and validating the phenotype of usb1 morphants. Co-injection 
of SMO-A and p53-MO, to check for potential off-target effects of the usb1-MO, resulted in a phenotype 
similar to that of only usb1-depleted embryos (Supplementary Fig. S2). In vivo analysis at 3 dpf showed 
that pericardial oedema, abnormal pigmentation and reduced circulating blood cells were all maintained 
(Supplementary Fig. S2).
Frequency of morphological phenotype (%) Std-MO usb1-SMO-A usb1-SMO-B
Pericardial oedema in AB line (2dpf) 34/741 (4%) 243/304 (80%) 255/433 (59%)
Abnormal pigmentation in AB line (2dpf) 0/741 71/123 (58%) 40/345 (12%)
Severely reduced circulation in AB line (2dpf) 34/741 (4%) 162/304 (53%) 205/433 (47%)
Cartilaginous defects in AB line (5dpf) 12/112 (11%) 80/99 (81%) 35/59 (59%)
Embryos tg(gata1:dsRED;flk1:GFP) with 
reduced expression of red signal 6/101 (6%) 53/85 (62%) n.p.
Embryos tg(mpx:GFP;lyzC:dsRED) with 
reduced expression of green signal 13/93 (14%) 77/110 (70%) n.p.
Table 1. Absolute number and percentage of each of the aberrant phenotypes observed in Std-MO, 
SMO-A or SMO-B injected embryos of wild-type (AB) and transgenic lines. n.p. =  not performed
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The specificity of the usb1 morphant phenotype was further corroborated by the co-injection of SMO-A 
and SMO-B at sub-phenotypic doses (each at 0.3 pmol/embryo) (Fig. 6a). When each morpholino was 
injected alone at this low dose, no phenotypic defects were observed. Conversely, the co-injection of 
both morpholinos at sub-critical doses induced an abnormal phenotype that was comparable to the one 
observed in the morphants injected with 0.6 pmol/embryo of SMO-A or SMO-B alone. In vivo analysis at 
2 dpf showed that 56% of double-injected morphants displayed a paucity of circulating cells and 70% had 
oedema (Fig. 6a), and Alcian blue staining at 5 dpf revealed that 71% of double-injected morphants had 
a defective architecture of pharyngeal arches respect to controls and to embryos injected with SMO-A 
or SMO-B at sub-phenotypic doses (Fig. 6b).
Rescue experiments were performed on the tg(mpx:GFP;lyzC:dsRED) line to further confirm the 
specificity of the usb1 MO-induced phenotype. Co-injection of human wild-type USB1 mRNA (300 pg/
embryo) together with SMO-A (0.6 pmol/embryo) rescued the usb1 morphant phenotype (Fig.  6c). At 
2 dpf, 58% of co-injected embryos were similar to the controls and had a normal circulation, at difference 
Figure 5. Effect of usb1 knockdown on haematopoiesis. (a) Real-time PCR analysis of pu.1, gata1 
and mpx expression at the indicated developmental stages of embryos injected with SMO-A or Std-MO 
(each at 0.6 pmol/embryo). Samples were run in triplicate and data are expressed as the mean ± standard 
deviation. Asterisks (*) indicate statistically significant differences (t- test; p < 0.05). (b) WISH of gata1 and 
mpx in SMO-A and control embryos at the indicated developmental stages. (c) O-dianisidine staining for 
haemoglobin in embryos injected with Std-MO (top), SMO-A (central) and SMO-B (bottom panels) (each 
at 0.6 pmol/embryo). The left and the right images are representative of the slight and severe erythropoiesis 
defects observed at the indicated percentages in SMO-A- and SMO-B-injected embryos. The # points to the 
caudal region of the morphant where the accumulation of blood is observed. Scale bars: (b,c) 200 μ m.
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of SMO-A injected embryos, of which only a small proportion (21%) was without defects in body struc-
ture and circulation (Fig. 6c, left panels).
Figure 6. Phenotypes of morphants co-injected with SMO-A and SMO-B at subphenotypic dosage 
and rescue of morpholino-induced phenotypes with human USB1 RNA. (a) Representative pictures of 
zebrafish embryos injected with Std-MO (0.6 pmol/embryo), SMO-A (0.3 pmol/embryo), SMO-B (0.3 pmol/
embryo) and co-injected with SMO-A and SMO-B (each at 0.3 pmol/embryo). (b) Alcian blue staining at 
5 dpf highlights the regular morphologic architecture of the pharyngeal arch cartilages in embryos injected 
with Std-MO, SMO-A and SMO-B at sub-phenotypic dosages and the aberrant cartilaginous structures in 
embryos co-injected with SMO-A and SMO-B (each at 0.3 pmol/embryo). (c) In the left panels, lateral views 
of 2 dpf embryos injected with Std-MO, SMO-A (0.6 pmol/embryo) and SMO-A and human USB1 RNA 
(300 pg/embryo). In the right panels, fluorescent images of tg(mpx:GFP;lyzC:dsRED) embryos at 2 dpf. The 
green signals, representing mpx-expressing cells, are reduced in embryos injected with SMO-A (0.6 pmol/
embryo) as compared to the controls, but are enhanced in embryos co-injected with human USB1 RNA 
(300 pg/embryo). The fractions of embryos exhibiting the investigated phenotypes out of the total number of 
those examined are indicated. All images are at the same magnification. Scale bars: 200 μ m.
www.nature.com/scientificreports/
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An increase of mpx-positive cells could also be appreciated in 55% of embryos co-injected with USB1 
RNA (300 pg/embryo) and SMO-A (0.6 pmol/embryo) (Fig. 6c, right panels), indicating recovery of the 
number of mature neutrophils.
Discussion
In this study we showed that the developmental abnormalities observed in patients affected by 
Poikiloderma with Neutropenia syndrome can be effectively recapitulated in zebrafish through the 
knockdown of the single usb1 gene. The two exploited splice-blocking MOs were both capable of giving 
rise to the signs of the human clinical spectrum, although SMO-A showed a higher penetrance of the 
abnormal phenotypic traits than SMO-B.
PN has two hallmarks: “poikiloderma” and mild to severe “neutropenia”. The latter predisposes to 
myelodysplasia and acute myeloid leukaemia3–6,12,13 thus featuring PN as a disorder of the haematopoi-
etic cascade, mainly of the myeloid lineage. Biochemical studies on yeast and lymphoblastoid cells from 
PN patients have shown that USB1 plays a crucial role in the stability and recycling of U6 snRNA, a 
component of the RNA splicing machinery16,17,18. As mutations affecting spliceosomal genes that result in 
defective splicing delineate a new leukaemogenic pathway20,21, the defective function of USB1 could take 
part in this pathomechanism. However, splicing defects could be observed only in the yeast model, not 
in PN lymphoblastoid cell lines, leaving the pathogenesis of PN incompletely understood22.
In line with the substantial evidence that the zebrafish is an excellent system for the study of hae-
matopoiesis during development23, our model, together with that recently generated by Patil et al.24, 
demonstrate that the usb1 gene has a key role in normal haematopoiesis and, when dysfunctional, leads 
to significant reduction of mature mpx-neutrophils, making it a candidate for a leukaemia-causing gene.
Both our SMO-A and SMO-B morphants engendered haematological defects, as shown by the signif-
icantly reduced expression of mpx in the tg(mpx:GFP;lyzC:dsRED) morphants. Furthermore, by injecting 
SMO-A into the tg(gata1:dsRED;flk1:GFP) line, it was possible to clarify cell lineage relationships and 
establish that the observed reduction in blood flow was due to haematopoietic deficiency rather than a 
vascular defect. Parallel analysis of haematopoiesis-specific markers by WISH and real-time PCR demon-
strated that the usb1 deficit impacted on the myeloid precursors traced by the pu.1 marker in 10 somites 
embryos, and on the downstream mature neutrophils, as revealed by the dramatic down-regulation of 
mpx expression in 22 hpf and 30 hpf morphants. This finding attests that the myeloid is the most severely 
affected lineage by usb1 knockdown during primitive haematopoiesis. There is a parallel between the 
neutropenia seen in the human syndrome, which clinically is revealed by recurrent infections, and the 
reduction in mpx-positive neutrophils in zebrafish cells that have been shown to have anti-inflammatory 
properties25. Furthermore, the effect of usb1 deficiency also affected the erythroid lineage, as mature 
red cells were reduced in number in 2 dpf SMO-A and SMO-B morphants. The expression levels of the 
erythroid progenitor marker gata1 were variable over time: a decreased expression was observed by 
WISH and real-time PCR analysis in the 22 hpf morphants and was documented in vivo in 2 dpf tg(ga-
ta1:dsRED;flk1:GFP) SMO-A morphants. Conversely, real-time PCR analysis of gata1 at 10 somites and 
30 hpf showed levels of expression comparable to those in control embryos.
Taken together, our haematological results indicate the involvement of usb1 early enough in the hae-
matopoietic cascade to affect erythro-myeloid precursors which are present prior to the emergence of 
multi-lineage haematopoietic stem cells26, although its preeminent effect is exerted downstream of the 
critical bifurcation point between erythroid and myeloid lineage.
Interestingly, although almost all PN patients show involvement of the myeloid lineage, a few have 
been reported with multi-lineage deficiency3,4,6,12,27,28.
Other clinical signs of PN, such as poikiloderma and skeletal defects, were fully reproduced by both 
SMO-A and SMO-B morphants. The impact of usb1 depletion on the zebrafish pigmentation and devel-
oping skeleton suggests that it is essential for the correct migration of ectoderm-derived neural crest-cells 
that differentiate in a wide spectrum of cell types, including melanocytes and craniofacial skeleton. 
Consistent with the physiological role of USB1 in the morphogenesis and homeostasis of developing 
skin and skin annexes, our SMO-A morphants, including those generated in the two transgenic lines, 
displayed stripes of pigment much thinner than those in the Std-MO-injected embryos. Reduction in 
the clusters of spotted pigment was also observed in SMO-B morphants, in a smaller percentage and to 
a less degree.
Skeletal defects, including osteopenia and delayed skeletal maturation, are suggested to be more fre-
quent in PN patients than reported, as they are mostly detectable only by X-ray5. The usb1 morphants 
had overt and massive defects of the pharyngeal arches-derived bones, particularly those involving the 
Meckel’s, palatoquadrate and ceratohyal structures. The severe disruption of a few branchial arches and 
associated cartilages accounts for the small head of the morphants and their craniofacial defects. The 
leaner and smaller body of the morphants in comparison to Std-MO-injected embryos mirrors the small 
stature of PN patients. Interestingly, the zebrafish model of Shwachman-Bodian-Diamond syndrome 
(SBDS; OMIM#260400), a well characterized defect of ribosome biogenesis associated with haematopoi-
etic dysfunction and increased cancer risk, due to mutations of the SBDS gene, is also characterized by 
skeletal defects in addition to chronic neutropenia29.
Moreover, the concurrence of skeletal defects, disorganized distribution of melanocytes and cardiac 
oedema has been observed in zebrafish with knockdown of the pinin (pnn) gene, which encodes a 
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nuclear and desmosome-associated protein that modulates alternative splicing of a specific subset of 
target genes30.
The observation that SMO-A, SMO-B and co-injection of both morpholinos at sub-phenotypic doses 
caused a similar alteration of the overall phenotype (body size, pericardial oedema, dyspigmentation 
and osteocartilagineous defects) and of haematopoietic stage-specific markers (mpx and O-dianisidine) 
confirms the specificity and efficiency of the two MO-mediated usb1-knockdowns. Moreover, the devel-
opmental defects observed in SMO-A morphants, as the reduced body size and the paucity of neutro-
phils, could be almost completely rescued by co-injection with human USB1 mRNA. All together these 
evidences indicate that the overall morphological and neutrophil abnormalities were caused by loss of 
usb1 and support the specific effect of SMO-A and SMO-B.
The overall phenotype of the morphants co-injected with p53-MO and SMO-A resembled that of usb1 
morphants, suggesting that usb1-knockdown effects have not been caused by aspecific p53-activation. This 
result is in line with similar findings obtained with the double sbds- and p53- knockdown morphants29.
Finally we want to comment our data taking into account the work of Patil et al.24 who exploited as 
we did the morpholino knockdown technology for successful modelling Poikiloderma with Neutropenia 
in zebrafish. Despite differing in the main focus and the prioritised experimental tools, a few merging 
issues are highlighted by both studies, in particular the impact of usb1 deficit on the neutrophil com-
mitment and differentiation.
Indeed, while Patil and coworkers mainly explored the neutrophil specific markers, also employ-
ing the most markedly affected ela3l (elastase) marker for the rescue experiments, linking the signifi-
cantly reduced number of neutrophils to incomplete splicing of the myeloid genes, we could monitor, by 
real-time PCR, the effect of defective usb1 at the level of the myeloid progenitor through the alteration 
of pu.1 expression. Our work also provides evidence on the multiple severe morphological abnormalities 
characteristic of the human syndrome which are associated with loss-of-function of the constitutively 
expressed usb1 gene. These include pigmentation and osteochondral defects which are fairly recapitu-
lated by SMO-A and SMO-B morphants and also by embryos co-injected with subphenotypic dosages of 
both morpholinos. Overall, the Japanese work and our study are well complementary and demonstrate 
the appropriate tool offered by the zebrafish model for further investigation of the pathogenesis of human 
PN syndrome.
Exploiting the zebrafish as a vertebrate model of PN, with its single highly-conserved usb1 gene, 
could provide a suitable evolutionary intermediate between yeast and human to carry out further bio-
chemichal studies aimed at clarifying the pathomechanism of PN. Targeted analysis of usb1-deficient 
zebrafish might lend insights suitable to be translated into therapies for the human disorder, particularly 
concerning the predisposition to myelodysplasia and acute myeloid leukaemia.
Methods
Zebrafish lines and maintenance. Zebrafish (Danio rerio) embryos were raised and maintained 
under standard conditions and national guidelines (Italian decree 4th March 2014, n.26). All experimen-
tal procedures were approved by IACUC (Institutional Animal Care and Use Committee).
Zebrafish AB strains obtained from the Wilson lab, University College London, London, United 
Kingdom and the transgenic lines tg(gata1:dsRED;flk1:GFP) kindly provided by the Santoro lab, Molecular 
biotechnology centre Università di Torino, Torino, Italia31, and tg(mpx:GFP;lyzC:dsRED) kindly provided 
by dr. Deflorian (IFOM Istituto FIRC di Oncologia Molecolare)32,33.
Embryos were staged according to morphological criteria34 and embryonic ages are expressed in 
somites (s), hour post fertilization (hpf) and day post fertilization (dpf). Since 24 hpf embryos were 
cultured in fish water containing 0,01% methylene blue to prevent fungal growth and 0,003% 1-phenyl-
2-thiourea (Sigma-Aldrich, Saint Louis, Missouri, USA) to prevent pigmentation in all experiments, 
except those aimed at evaluating the skin phenotype.
Embryos were washed, dechorionated and anaesthetized, with 0.016% tricaine (Ethyl 3-aminobenzoate 
methanesulfonate salt; Sigma-Aldrich), before observations and picture acquisitions. Embryos were fixed 
overnight in 4% paraformaldehyde (Sigma-Aldrich) in PBS at 4 °C, then dehydrated stepwise to metha-
nol and stored at − 20 °C.
usb1 identification. The human USB1 amino-acid sequence was used as a query to identify in-silico 
the zebrafish usb1 gene. NCBI (http://www.ncbi.nlm.nih.gov/BLAST/), ClustalW (http://www.ebi.ac.uk/
Tools/clustalw/) and SMART (http://smart.embl-heidelberg.de/) tools were used for basic handling and 
analyses of the nucleotide and protein sequences.
Analysis of synteny was performed with Genomicus software, version 57.01 (http://www.dyogen.ens.
fr/genomicus-69.01/cgi-bin/search.pl).
Expression analysis. Total RNAs were isolated from embryos at different developmental stages and 
from different adult organs using the “SV Total RNA Isolation System” (Promega, Madison, Wisconsin, 
USA).
After treatment with DNase I RNase-free (Roche, Basel, Switzerland) to avoid possible genomic con-
tamination, 1 μ g of RNA was reverse-transcribed using the “ImProm-II™ Reverse Transcription System” 
(Promega) and random primers according to manufacturer’s instructions.
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According to the sequence information gained from bioinformatic analysis, we amplified a fragment 
and the full coding sequence of usb1 (primers F-R and F-R2, respectively; Supplementary Table S1) using 
GoTaq polymerase (Promega) following the manufacturer’s instructions. Specific β-actin primers35 were 
also used to check cDNA quality and possible genomic contamination. Reaction products were analysed 
by 1% agarose-gel electrophoresis. Amplicons were sequenced using Big Dye Terminator v.3.1 Cycle 
Sequencing Kit according to the manufacturer’s protocol on the ABI PRISM 3130 sequencer (Applied 
Biosystems, Foster City, California, USA). Electropherograms were analyzed with ChromasPro software 
1.42 (Technelysium Pty Ltd, Tewantin QLD, Australia) using NM_001003460 as reference.
The full coding region of usb1 was cloned into pCR™ 4-TOPO® TA vector using “TA Topocloning for 
sequencing” (Invitrogen, Paisley, UK).
Sense and antisense RNA probes were respectively transcribed using T7 and T3 RNA polymerase 
(Roche) on templates linearized with SpeI or NotI (New England Biolabs Inc, Ipswich, Massachusetts, 
USA). Probes were labelled with digoxigenin using the “DIG-RNA Labelling Kit” (Roche).
WISH was performed as described36 with BM-Purple (Roche) as substrate. Controls with sense ribo-
probes were performed in parallel with antisense analyses.
Images of stained embryos were taken on a Leica MZFLIII epifluorescence stereomicroscope equipped 
with a DFC 480 digital camera and LAS Leica imaging software (Leica, Wetzlar, Germany).
Morpholinos-mediated knockdown, phenotype analysis and rescue experiments. Antisense 
morpholinos (MOs; GeneTools, Philomath, Oregon, USA) were designed against the acceptor splice 
site of the usb1 IVS2 (SMO-A, 5′–GGATCATCTGAAATTTAGGCAGGAA-3′ ) and IVS4 (SMO-B, 
5′–CCAAGAAAAGTCCTGCGTCAACAAT-3′ ). A standard control oligo (Std-MO) with no target in 
zebrafish embryos, to check for nonspecific effects due to the injection procedure and p53-MO were also 
used according to previous reports37,38.
All morpholinos were diluted in Danieau solution39 and pressure-injected into 1- to 2-cell-stage 
embryos using Eppendorf FemtoJet Micromanipulator 5171. Rhodamine dextran (Molecular Probes, 
Life technology) was usually co-injected as dye tracer. The optimal dose for each MO was selected based 
on phenotypic effect.
RT-PCR analysis to determine efficacy of SMO splicing inhibition was carried out on RNA isolated 
from 2 dpf embryos using Go Taq polymerase (Promega) and F2-R3 and F-R2 usb1 specific primers 
(Supplementary Table S1). Amplicons were sequenced as above mentioned.
Alcian blue and O-dianisidine staining were performed as described40,41.
Probes for pu.142, mpx25, gata143 and clmc244 were synthesized and used for WISH on at least 2 batches 
of control and morphant embryos at each developmental stage.
Real-time PCR was performed with Fast SYBR Green Master Mix (Applied Biosystems) using the 
StepOne real-time PCR System (Applied Biosystems). Actin was chosen as endogenous normalising gene 
and relative expression of target genes (mpx, gata1 and pu.1) was determined using the Δ Δ Ct method45.
Total RNA was isolated from at least three batches each of 30–40 embryos injected with usb1-SMO-A 
and Std-MO at the indicated developmental stages (10 s, 22 hpf and 30 hpf) using SV Total RNA Isolation 
System (Promega). All samples were retro-transcribed in two independent experiments, each RT product 
was run in triplicate and standard deviation (s.d.) was calculated.
Sequences of primers used for real-time PCR are listed in Supplementary Table 2.
Statistics comparisons between groups of data were evaluated using the t test. A p-value < of 0.05 was 
considered statistically significant.
Total human RNA was reverse-transcribed into cDNA using High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems) with random primers; then the full-length wild-type USB1 was 
PCR-amplified (primer forward 5′-cggttgaggttgctggtgg-3′ ; primer reverse 5′-gttcctccatctcagcctg-3′ ). The 
amplicon was subcloned into the pCS2+ poly(A) vector and then used as template for generating sense 
RNA, in vitro synthesized using the “mMessage mMachine kit” (Ambion, Austin, Texas, USA) according 
to the manufacturer’s instructions. The synthesized mRNAs, diluted in RNase-free water, was injected 
into one- or two-cell-stage embryos.
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